Literature DB >> 34034346

Radiological CT Patterns and Distribution of Invasive Pulmonary Aspergillus, Non-Aspergillus, Cryptococcus and Pneumocystis Jirovecii Mold Infections - A Multicenter Study.

Verena C Obmann1, Flurina Bickel1, Nicola Hosek1, Lukas Ebner1, Adrian T Huber1, Lauro Damonti2, Stefan Zimmerli2, Andreas Christe1.   

Abstract

PURPOSE: Clinical signs and symptoms related to invasive fungal disease are nonspecific and need to be followed up by appropriate diagnostic procedures. The goal of this study was to analyze CT imaging patterns in invasive fungal infections and their correlation with the immune status and clinical outcome.
MATERIALS AND METHODS: We performed a retrospective multicenter study including 85 consecutive patients with invasive pulmonary fungal infection (2011-2014). Lung patterns on computed tomography (CT) scans were classified according to the Fleischner Society glossary. The patients were grouped according to immune status (neutropenia, steroid therapy, organ transplant recipient, and other cause) and outcome (positive outcome, progressive disease, and death). The Chi square test or Fisher exact test was used. Bonferroni correction was applied.
RESULTS: The total number of patients with invasive Aspergillus and non-Aspergillus infection (IANA), Pneumocystis jirovecii pneumonia (PCP), and Cryptococcus (CRY) was 60, 22, and 3, respectively. Patients with IANA demonstrated significantly more nodules (93 % vs. 59 %, p = 0.001), significantly fewer ground glass opacities (58 % vs. 96 %, p = 0.005), and significantly fewer positive lymph nodes (5 % vs. 41 %, p < 0.001) than patients with PCP. All patients with PCP and CRY had a favorable outcome. Patients with IANA and an adverse outcome demonstrated significantly more nodules with halo sign than patients with IANA and a favorable outcome (42.5 % vs. 15.9 %, p < 0.0001). Interestingly, patients with IANA and a favorable outcome had a higher prevalence of pulmonary infarction than patients with an adverse outcome (8 % vs. 1 %, p = 0.047). Patients with neutropenia showed significantly more consolidations (66 %) than organ transplant recipients (27 %, p = 0.045).
CONCLUSION: Patients with IANA showed a higher prevalence of nodules and a lower prevalence of ground glass opacities than patients with PCP. In patients with IANA, nodules with halo sign were associated with an adverse outcome. Patients with neutropenia showed generally more consolidations, but the consolidations were not associated with an adverse outcome. KEY POINTS: · Nodules, ground glass opacities, and consolidations are common CT findings in all invasive pulmonary fungal infections.. · There is no pattern that is unique for one specific pathogen, although nodules are more predominant in IANA and Cryptococcus, and ground glass opacities are more predominant in PCP patients.. · Immune status had an impact on CT findings in fungal pneumonia with less consolidation in patients after organ transplantation compared to patients with neutropenia.. · Nodules with a halo sign are associated with a worse outcome.. CITATION FORMAT: · Obmann VC, Bickel F, Hosek N et al. Radiological CT Patterns and Distribution of Invasive Pulmonary Aspergillus, Non-Aspergillus, Cryptococcus and Pneumocystis Jirovecii Mold Infections - A Multicenter Study. Fortschr Röntgenstr 2021; 193: 1304 - 1314. Thieme. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34034346     DOI: 10.1055/a-1482-8336

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  2 in total

1.  Clinical diagnosis, treatment, and medical identification of specific pulmonary infection in naval pilots: Four case reports.

Authors:  Jia Zeng; Guo-Li Zhao; Jia-Cheng Yi; Dan-Dan Liu; Yan-Qing Jiang; Xiang Lu; Yan-Bing Liu; Fei Xue; Jie Dong
Journal:  World J Clin Cases       Date:  2022-06-06       Impact factor: 1.534

2.  Pneumocystis jiroveci pneumonia after total hip arthroplasty in a dermatomyositis patient: A case report.

Authors:  Mao Hong; Zi-Yu Zhang; Xiao-Wei Sun; Wei-Guo Wang; Qi-Dong Zhang; Wan-Shou Guo
Journal:  World J Clin Cases       Date:  2022-04-06       Impact factor: 1.534

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.